Skip to main content

Table 3 The Comparison of the Biochemical Values of the Groups

From: Antiviral therapy in neonatal cholestatic cytomegalovirus hepatitis

Groups   T. billirubin
mean ± sd median
D. Billirubin
mean ± sd median
ALT
mean ± sd median
AST
mean ± sd median
ALP
mean ± sd median
GGT
mean ± sd median
Group 1 n = 7 Initial *4.6 ± 3.2
4.6
*3.9 ± 2.5
4
*119.4 ± 56.4
80
*167 ± 68.4
197
*1148 ± 300
750
4414 ± 186.3
110
  Posttreatment 1.29 ± 0.82
2.5
0.53 ± 0.27
0.3
53 ± 18.5
54
75 ± 28.1
58
556 ± 196.5
324
150.7 ± 61.5
71
Group 2 n = 5 Initial **2.52 ± 1.07
1.45
**1.42 ± 0.45
0.25
**172.7 ± 57.6
92
**155.2 ± 68
93
**393.5 ± 44.7
381
67.7 ± 25
49
  Control 4.37 ± 2.21
0.3
2.97 ± 1.75
0.1
123.2 ± 18.5
98
152.7 ± 47
116.5
435.7 ± 37.5
311
73.2 ± 24.6
51
  1. Comparison of initial and post treatment values among Group 1
  2. p < 0.01
  3. * p < 0.05
  4. Comparison of initial and control values among Group 2
  5. **, NS